A groundbreaking brain imaging study shows why the gold-standard Parkinson’s drug doesn’t work for everyone—and how doctors ...

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?

Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...

Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Researchers have used magnetoencephalography brain imaging technology to determine how the drug levodopa, the main drug used ...

Parkinson's disease is traditionally associated with neurological damage in the brain, brought on by a drastic drop in ...

New research uncovers brain changes in Parkinson's disease. Feb 12, 2025. How the Parkinson's drug Levodopa causes psychiatric complications similar to drug abuse. Sep 11, 2024.

A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.

Diagnosing Parkinson's disease has always been a race against time. The later it’s found, the harder it is to treat.

Elizabeth Jonas first got interested in mitochondria by chance. In 1995, she was a postdoctoral researcher at Yale, working ...